# An Observational Study to Evaluate the Safety and Efficacy of Humacyte's HAV for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma

> **NCT05873959** · — · COMPLETED · sponsor: **Humacyte, Inc.** · enrollment: 17 (actual)

## Conditions studied

- Trauma
- Trauma Injury
- Trauma, Multiple
- Trauma Blunt

## Interventions

- **BIOLOGICAL:** HAV implantation

## Key facts

- **NCT ID:** NCT05873959
- **Lead sponsor:** Humacyte, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2023-05-26
- **Final completion:** 2024-01-15
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05873959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05873959, "An Observational Study to Evaluate the Safety and Efficacy of Humacyte's HAV for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05873959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*